The clinical characteristic of alcohol-hyperlipidemia etiologically complex type of acute pancreatitis.
Chen EX, Tu Ya SQ, She ZF, Wang HM, Yang PF, Wang YH, Xu ZH, Hao BJ, Cao X, Mao EQ.
Eur Rev Med Pharmacol Sci. 2022 Oct;26(19):7212-7218. doi: 10.26355/eurrev_202210_29913.
Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.
Zheng ZG, Zhu ST, Cheng HM, Zhang X, Cheng G, Thu PM, Wang SP, Li HJ, Ding M, Qiang L, Chen XW, Zhong Q, Li P, Xu X.
Autophagy. 2021 Jul;17(7):1592-1613. doi: 10.1080/15548627.2020.1757955. Epub 2020 May 20.
Hyperlipidemia and atherosclerosis.
Ross R, Harker L.
Science. 1976 Sep 17;193(4258):1094-100. doi: 10.1126/science.822515.
[Hyperlipidemia: complex pathophysiology caused by multiple genetic and environmental factors--in considering the approaches to preventive medicine].
Nobukuni Y, Higashikawa F, Miyagawa K, Eboshida A.
Nihon Eiseigaku Zasshi. 2005 Nov;60(4):426-41. doi: 10.1265/jjh.60.426.
Genetically defined hyperlipidemia.
Smit JW, Diamant M.
Pharmacogenomics. 2004 Apr;5(3):295-304. doi: 10.1517/phgs.5.3.295.29835.
Assessment of the hyperlipidemia risk for residents exposed to potential emitted metals in the vicinity of a petrochemical complex.
Shun CH, Yuan TH, Hung SH, Yeh YP, Chen YH, Chan CC.
Environ Sci Pollut Res Int. 2021 Jun;28(22):27966-27975. doi: 10.1007/s11356-021-12642-1. Epub 2021 Feb 1.
Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E, Farahani N, Mardani R, Taheri F, Taghizadeh H, Gheibihayat SM.
Biochem Genet. 2022 Apr;60(2):453-481. doi: 10.1007/s10528-021-10130-2. Epub 2021 Sep 3.
Dyslipidaemia.
Durrington P.
Lancet. 2003 Aug 30;362(9385):717-31. doi: 10.1016/S0140-6736(03)14234-1.
FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
Bello-Chavolla OY, Kuri-García A, Ríos-Ríos M, Vargas-Vázquez A, Cortés-Arroyo JE, Tapia-González G, Cruz-Bautista I, Aguilar-Salinas CA.
Rev Invest Clin. 2018;70(5):224-236. doi: 10.24875/RIC.18002575.
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia.
Larouche M, Khoury E, Brisson D, Gaudet D.
Curr Atheroscler Rep. 2023 Dec;25(12):1101-1111. doi: 10.1007/s11883-023-01179-y. Epub 2023 Dec 14.
